Your browser doesn't support javascript.
loading
Spatio-temporal dynamics of intra-host variability in SARS-CoV-2 genomes.
Pathak, Ankit K; Mishra, Gyan Prakash; Uppili, Bharathram; Walia, Safal; Fatihi, Saman; Abbas, Tahseen; Banu, Sofia; Ghosh, Arup; Kanampalliwar, Amol; Jha, Atimukta; Fatma, Sana; Aggarwal, Shifu; Dhar, Mahesh Shanker; Marwal, Robin; Radhakrishnan, Venkatraman Srinivasan; Ponnusamy, Kalaiarasan; Kabra, Sandhya; Rakshit, Partha; Bhoyar, Rahul C; Jain, Abhinav; Divakar, Mohit Kumar; Imran, Mohamed; Faruq, Mohammed; Sowpati, Divya Tej; Thukral, Lipi; Raghav, Sunil K; Mukerji, Mitali.
Afiliação
  • Pathak AK; CSIR - Institute of Genomics and Integrative Biology (CSIR-IGIB), Delhi, India.
  • Mishra GP; Institute of Life Sciences (ILS), Bhubaneswar, Odisha, India.
  • Uppili B; CSIR - Institute of Genomics and Integrative Biology (CSIR-IGIB), Delhi, India.
  • Walia S; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
  • Fatihi S; Institute of Life Sciences (ILS), Bhubaneswar, Odisha, India.
  • Abbas T; CSIR - Institute of Genomics and Integrative Biology (CSIR-IGIB), Delhi, India.
  • Banu S; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
  • Ghosh A; CSIR - Institute of Genomics and Integrative Biology (CSIR-IGIB), Delhi, India.
  • Kanampalliwar A; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
  • Jha A; CSIR - Centre for Cellular and Molecular Biology (CSIR-CCMB), Hyderabad, Telangana, India.
  • Fatma S; Institute of Life Sciences (ILS), Bhubaneswar, Odisha, India.
  • Aggarwal S; Institute of Life Sciences (ILS), Bhubaneswar, Odisha, India.
  • Dhar MS; Institute of Life Sciences (ILS), Bhubaneswar, Odisha, India.
  • Marwal R; Institute of Life Sciences (ILS), Bhubaneswar, Odisha, India.
  • Radhakrishnan VS; Institute of Life Sciences (ILS), Bhubaneswar, Odisha, India.
  • Ponnusamy K; Biotechnology Division, National Centre for Disease Control (NCDC), New Delhi, India.
  • Kabra S; Biotechnology Division, National Centre for Disease Control (NCDC), New Delhi, India.
  • Rakshit P; Biotechnology Division, National Centre for Disease Control (NCDC), New Delhi, India.
  • Bhoyar RC; Biotechnology Division, National Centre for Disease Control (NCDC), New Delhi, India.
  • Jain A; Biotechnology Division, National Centre for Disease Control (NCDC), New Delhi, India.
  • Divakar MK; Biotechnology Division, National Centre for Disease Control (NCDC), New Delhi, India.
  • Imran M; CSIR - Institute of Genomics and Integrative Biology (CSIR-IGIB), Delhi, India.
  • Faruq M; CSIR - Institute of Genomics and Integrative Biology (CSIR-IGIB), Delhi, India.
  • Sowpati DT; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
  • Thukral L; CSIR - Institute of Genomics and Integrative Biology (CSIR-IGIB), Delhi, India.
  • Raghav SK; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
  • Mukerji M; CSIR - Institute of Genomics and Integrative Biology (CSIR-IGIB), Delhi, India.
Nucleic Acids Res ; 50(3): 1551-1561, 2022 02 22.
Article em En | MEDLINE | ID: mdl-35048970
During the course of the COVID-19 pandemic, large-scale genome sequencing of SARS-CoV-2 has been useful in tracking its spread and in identifying variants of concern (VOC). Viral and host factors could contribute to variability within a host that can be captured in next-generation sequencing reads as intra-host single nucleotide variations (iSNVs). Analysing 1347 samples collected till June 2020, we recorded 16 410 iSNV sites throughout the SARS-CoV-2 genome. We found ∼42% of the iSNV sites to be reported as SNVs by 30 September 2020 in consensus sequences submitted to GISAID, which increased to ∼80% by 30th June 2021. Following this, analysis of another set of 1774 samples sequenced in India between November 2020 and May 2021 revealed that majority of the Delta (B.1.617.2) and Kappa (B.1.617.1) lineage-defining variations appeared as iSNVs before getting fixed in the population. Besides, mutations in RdRp as well as RNA-editing by APOBEC and ADAR deaminases seem to contribute to the differential prevalence of iSNVs in hosts. We also observe hyper-variability at functionally critical residues in Spike protein that could alter the antigenicity and may contribute to immune escape. Thus, tracking and functional annotation of iSNVs in ongoing genome surveillance programs could be important for early identification of potential variants of concern and actionable interventions.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Variação Genética / Genoma Viral / Evolução Molecular / Interações Hospedeiro-Patógeno / SARS-CoV-2 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals País/Região como assunto: Asia Idioma: En Revista: Nucleic Acids Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Variação Genética / Genoma Viral / Evolução Molecular / Interações Hospedeiro-Patógeno / SARS-CoV-2 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals País/Região como assunto: Asia Idioma: En Revista: Nucleic Acids Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia